Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Transamination Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113292495B details a high-yield synthesis of (S)-amino benazepril intermediate using quinine-derived catalysis, offering significant cost and safety advantages for API manufacturing.
Breakthrough chiral biaryl pyridoxamine catalyst enables high-yield asymmetric transamination with mild conditions, offering reliable supply chain for pharmaceutical intermediates.